Announcements

Conference: APHA 2025 Annual Meeting and Expo
Date: 2–5 November 2025
Location: Washington, D.C., USA

The American Public Health Association was founded in 1872. The first APHA Annual Meeting and Expo took place in Cincinnati, Ohio, in 1873, and each year, approximately 12,000 public health professionals and partners from around the world participate in this event. The Annual Meeting garners many professionals across various disciplines, offering them a platform to engage and collaborate with others in the field and gain further insights. Moreover, research has shown that public health efforts to prevent disease are more cost-effective—and humane—than treating chronic health conditions.

The following MDPI journals will be represented at APHA 2025:

• IJERPH;
• Pharmacy;
• Vaccines;
• Hygiene;
• Epidemiologia;
• Infectious Disease Reports;
• Healthcare;
• Adolescents;
• Women;
• Therapeutics;
• Allergies;
• Diseases;
• Nursing Reports;
• Children;
• Journal of Respiration.

Our delegates look forward to meeting you in person at our booth and answering any questions you may have. For more information regarding this conference, please visit the following link: https://www.apha.org/events-and-meetings/annual.

Conference: 2025 TERMIS-AM Conference
Date: 9–12 November 2025
Location: Detroit, USA

MDPI will be attending the 2025 TERMIS-AM Conference as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.

The Americas Chapter of the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AM) promotes education and research in tissue engineering and regenerative medicine within North and South America through its annual conferences, networking events, and volunteer-driven programs like the Ambassadors Program. TERMIS-AM serves as a key international forum for discussion, collaboration, and advancing knowledge in the field to improve patient outcomes globally.

The programming for the 2025 conference will focus on “Next Generation Tools for Regenerative Medicine”.

The following MDPI journals will be represented at the conference:

• Bioengineering;
• Biomedicines;
• Diseases;
• Reports;
• Emergency Care and Medicine;
• BioTech;
• Thalassemia Reports;
• BioMed;
• J;
• JPBI;
• Pharmacoepidemiology.

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://am2025.termis.org/.

The International Day for Interventional Cardiology is observed annually on 16 September. This day is dedicated to raising awareness about the field of interventional cardiology and its role in treating heart diseases through minimally invasive procedures. It highlights advancements and achievements in the field, emphasizing the importance of cardiovascular health and innovative medical interventions.

In recognition of this important day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine. We believe that promoting such research contributes to enhanced public awareness and a greater understanding of cardiovascular diseases and procedures, related complications, prevention and care.

“Cellular and Molecular Bases for the Application of Polyphenols in the Prevention and Treatment of Cardiovascular Disease”
by Carlo Caiati and Emilio Jirillo
Diseases 2025, 13(7), 221; https://doi.org/10.3390/diseases13070221

“Comparative Analysis of Cardiovascular Outcomes in Type 2 Diabetes Patients Engaging in Aerobic, Resistance, and Combined Training: A Systematic Review”
by Sayed Alireza Mousavi Zadeh, Giuseppe Caminiti, Maurizio Aracri, Massimo Pieri, Anna Paola Mitterhofer, Antonino De Lorenzo, Sergio Bernardini, Pasquale Farsetti, Maurizio Volterrani, Rosario Barone et al.
Diabetology 2025, 6(5), 38; https://doi.org/10.3390/diabetology6050038

“Medical Therapy Versus Percutaneous Coronary Intervention in Patients with Myocardial Bridging from a National Population-Based Cohort Study: The Use of Big Data Analytics”
by Chayakrit Krittanawong, Song Peng Ang, Fernando Alexis Padilla, Yusuf Kamran Qadeer, Zhen Wang, Nicola Gaibazzi, Samin K. Sharma, Carl J. Lavie, Hartzell V. Schaff and Ernst R. Schwarz
Cardiogenetics 2025, 15(2), 10; https://doi.org/10.3390/cardiogenetics15020010

“Computed Tomography Angiography Identified High-Risk Coronary Plaques: From Diagnosis to Prognosis and Future Management”
by Kyriakos Dimitriadis, Nikolaos Pyrpyris, Panagiotis Theofilis, Emmanouil Mantzouranis, Eirini Beneki, Panagiotis Kostakis, George Koutsopoulos, Konstantinos Aznaouridis, Konstantina Aggeli and Konstantinos Tsioufis
Diagnostics 2024, 14(15), 1671; https://doi.org/10.3390/diagnostics14151671

“Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures”
by Nikolaos Ktenopoulos, Odysseas Katsaros, Anastasios Apostolos, Maria Drakopoulou, Grigorios Tsigkas, Constantinos Tsioufis, Periklis Davlouros, Konstantinos Toutouzas and Antonios Karanasos
Life 2024, 14(7), 842; https://doi.org/10.3390/life14070842

“Zero-Fluoroscopy Catheter Ablation of Right Appendage Focal Atrial Tachycardia in a Pregnant Woman”
by Federica Troisi, Noemi Valenti, Federico Quadrini, Nicola Vitulano, Antonio Di Monaco, Imma Romanazzi, Rosa Caruso, Rocco Orfino and Massimo Grimaldi
Clin. Pract. 2024, 14(3), 946-953; https://doi.org/10.3390/clinpract14030075

“In-Stent Restenosis Overview: From Intravascular Imaging to Optimal Percutaneous Coronary Intervention Management”
by Neda Shafiabadi Hassani, Lucas Carlini Ogliari, Pedro Rafael Vieira de Oliveira Salerno, Gabriel Tensol Rodrigues Pereira, Marcelo Harada Ribeiro and Luis Augusto Palma Dallan
Medicina 2024, 60(4), 549; https://doi.org/10.3390/medicina60040549

“The Application of Precision Medicine in Structural Heart Diseases: A Step towards the Future”
by Grigorios Chrysostomidis, Anastasios Apostolos, Amalia Papanikolaou, Konstantinos Konstantinou, Grigorios Tsigkas, Antigoni Koliopoulou and Themistokles Chamogeorgakis
J. Pers. Med. 2024, 14(4), 375; https://doi.org/10.3390/jpm14040375

“Different Mechanisms in Doxorubicin-Induced Cardiomyopathy: Impact of BRCA1 and BRCA2 Mutations”
by Hien C. Nguyen, Jefferson C. Frisbee and Krishna K. Singh
Hearts 2024, 5(1), 54-74; https://doi.org/10.3390/hearts5010005

“Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease”
by Keith A. Webster
Genes 2024, 15(1), 135; https://doi.org/10.3390/genes15010135

“A Refractory Electrical Storm after Acute Myocardial Infarction: The Role of Temporary Ventricular Overdrive Pacing as a Bridge to ICD Implantation”
by Mijo Meter and Josip Andelo Borovac
Pathophysiology 2024, 31(1), 44-51; https://doi.org/10.3390/pathophysiology31010004

“Transcatheter Aortic Valve Replacement: Current Status and Future Indications”
by Manish Vinayak, Pier Pasquale Leone, Richard Tanner, Vishal Dhulipala, Anton Camaj, Rakhee Rajendra Kumar Makhija, Amit Hooda, Annapoorna S. Kini, Samin K. Sharma and Sahil Khera
J. Clin. Med. 2024, 13(2), 373; https://doi.org/10.3390/jcm13020373

“Gender Disparities after Transcatheter Aortic Valve Replacement with Newer Generation Transcatheter Heart Valves: A Systematic Review and Meta-Analysis”
by Angkawipa Trongtorsak, Sittinun Thangjui, Pabitra Adhikari, Biraj Shrestha, Jakrin Kewcharoen, Leenhapong Navaravong, Somsupha Kanjanauthai, Steve Attanasio and Hammad A. Saudye
Med. Sci. 2023, 11(2), 33; https://doi.org/10.3390/medsci11020033

Conference: 38th Annual Congress of the European Association of Nuclear Medicine
Date: 4–8 October 2025
Location: Barcelona, Spain

We are pleased to announce that MDPI will participate in the 38th Annual Congress of the European Association of Nuclear Medicine (EANM25), to be held in Barcelona, Spain, from 4 to 8 October 2025.

One of the highlights of this year’s congress will be the continued focus on novel advances in theranostics. This rapidly evolving field continues to revolutionize our approach to diagnosis and treatment, offering unprecedented precision and personalized care for our patients. We have an exciting program lined up, featuring leading experts who will share their insights and latest research findings.

MDPI is excited to participate in this prestigious event! Representing the journal Diagnostics (ISSN: 2075-4418), Ms. Florina Maria Muresan and Ms. Lassie Shu will be present at the MDPI exhibition stand, where they will warmly welcome all scholars to stop by and engage in insightful discussions. This event presents a unique opportunity for participants to interact with leading experts in the field and explore potential collaborations. Do not miss the chance to visit our stand and exchange ideas with the MDPI editors and other delegates!

The following MDPI journals will be represented at the conference:

• Diagnostics;
• Diseases;
• Cancers;
• JCM;
• JPM;
• Medical Sciences;
• Tomography;
• Medicina;
• J. Imaging;
• Current Oncology;
• Uro.

If you are planning to attend the conference, please feel free to start a conversation with us. We invite all conference attendees to visit MDPI’s booth and meet with our esteemed Editorial Board Members.

For more information about the conference, please visit the following website: https://eanm25.eanm.org/.

Duchenne muscular dystrophy is a condition that, while currently incurable, is the focus of extensive research aimed at prevention and treatment to improve the health and quality of life for those affected. Each year, we observe World Duchenne Awareness Day to enhance public understanding of the profound health, social, and economic impacts of Duchenne muscular dystrophy (DMD) and to bolster our efforts in combating this condition.

The day marks the birthday of Guillaume Duchenne, the physician who first described the disorder in the 19th century, thus setting the stage for advancements in diagnosis and care. It is our hope that esteemed journals in the fields of Biology, Life Sciences, and Medicine & Pharmacology at MDPI will continue to act as forums for the dissemination of cutting-edge research and innovative concepts related to the prevention and treatment of Duchenne muscular dystrophy.

“CRISPR/Cas9-Targeted Myostatin Deletion Improves the Myogenic Differentiation Parameters for Muscle-Derived Stem Cells in Mice”
by Mohamed I. Elashry, Victoria C. Schneider, Manuela Heimann, Sabine Wenisch and Stefan Arnhold
J. Dev. Biol. 2025, 13(1), 5; https://doi.org/10.3390/jdb13010005

“Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study”
by Victor Augusto Ramos Fernandes, Gabriela Pereira dos Santos, Amilton Iatecola, Daniela Vieira Buchaim, Ionaly Judith Faria Garcia, Carlos Henrique Bertoni Reis, Lívia Maluf Menegazzo Bueno, Bruna Trazzi Pagani, Rogerio Leone Buchaim and Marcelo Rodrigues da Cunha
Pathophysiology 2025, 32(1), 2; https://doi.org/10.3390/pathophysiology32010002

“Appendicular Skeletal Muscle Index Is Positively Related to Mediterranean Diet Adherence in University Students”
by Paraskevi Detopoulou, Olga Magni, Ioanna Pylarinou, Despoina Levidi, Vassilios Dedes, Milia Tzoutzou, Konstantina Argyri, Evangelia Fappa, Aristea Gioxari and George Panoutsopoulos
Diseases 2025, 13(1), 3; https://doi.org/10.3390/diseases13010003

“MRI-Based Circumferential Strain in Boys with Early Duchenne Muscular Dystrophy Cardiomyopathy”
by Zhan-Qiu Liu, Nyasha G. Maforo, Patrick Magrath, Ashley Prosper, Pierangelo Renella, Nancy Halnon, Holden H. Wu and Daniel B. Ennis
Diagnostics 2024, 14(23), 2673; https://doi.org/10.3390/diagnostics14232673

“An Updated Analysis of Exon-Skipping Applicability for Duchenne Muscular Dystrophy Using the UMD-DMD Database”
by Jamie Leckie, Abdullah Zia and Toshifumi Yokota
Genes 2024, 15(11), 1489; https://doi.org/10.3390/genes15111489

“A Comprehensive Workplace Exercise Intervention to Reduce Musculoskeletal Pain and Improve Functional Capacity in Office Workers: A Randomized Controlled Study”
by Konstantina Karatrantou and Vassilis Gerodimos
Healthcare 2024, 12(9), 915; https://doi.org/10.3390/healthcare12090915

“Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI”
by Lara Schlaffke, Robert Rehmann, Anne-Katrin Güttsches, Matthias Vorgerd, Christine H. Meyer-Frießem, Hubert R. Dinse, Elena Enax-Krumova, Martijn Froeling and Johannes Forsting
J. Clin. Med. 2024, 13(7), 1958; https://doi.org/10.3390/jcm13071958

“Nuclear Small Dystrophin Isoforms during Muscle Differentiation”
by Tina Donandt, Vanessa Todorow, Stefan Hintze, Alexandra Graupner, Benedikt Schoser, Maggie C. Walter and Peter Meinke
Life 2023, 13(6), 1367; https://doi.org/10.3390/life13061367

“Orphan Drugs in Neurology—A Narrative Review”
by Carmen Adella Sirbu, Raluca Ivan, Francois Jerome Authier, Florentina Ionita-Radu, Dragos Catalin Jianu, Octavian Vasiliu, Ciprian Constantin and Sorin Tuță
J. Pers. Med. 2023, 13(3), 420; https://doi.org/10.3390/jpm13030420

“Muscle Wasting, Aging, and Cancer: The Effects of Physical Exercise” Guest Editor: Prof. Dr. Paula Tavares Submission deadline: 28 November 2025	“Genetic Diagnosis and Treatment of Duchenne Muscular Dystrophy” Guest Editor: Dr. Liubov V. Gushchina Submission deadline: 20 December 2025
“Muscular Dystrophy: From Molecular Basis to Therapies: 2nd Edition” Guest Editor: Dr. Francesca Sciandra and Dr. Kinga I. Gawlik Submission deadline: 15 January 2026	“Dysfunctions or Approaches of the Musculoskeletal System” Guest Editors: Prof. Dr. Paloma Moro and Prof. Dr. Jorge Rodriguez Submission deadline: 28 February 2026
“Neuromuscular Diseases and Musculoskeletal Disorders” Guest Editor: Dr. Anna Christakou Submission deadline: 28 February 2026	“Mitochondrial Function and Dysfunction in Developmental Biology Metabolism” Guest Editor: Prof. Dr. Simon J. Conway Submission deadline: 15 March 2026

Date: 23 September 2025
Time: 11:00 a.m.–4:30 p.m
Location: The Chelsea Hotel, 33 Gerrard Street West, Toronto

MDPI is thrilled to announce our participation in the University of Toronto’s largest career fair, taking place at the St. George Downtown Campus. This exciting event brings together thousands of students, graduates, and professionals looking to connect with top employers and explore career opportunities.

We invite all attendees to visit the MDPI booth to discover how you can be part of one of the world’s leading open access academic publishers. Whether you are passionate about scientific research, editorial work, marketing, or supporting global innovation in publishing, we want to meet YOU!

What to expect at our booth:

• Learn more about MDPI’s mission and global impact;
• Explore exciting career opportunities in publishing, editorial, communications, and more;
• Network with our team and ask questions about working at MDPI.

Whether you’re just starting your career or looking to take the next step, don’t miss this opportunity to connect with MDPI. Bring your resume, your curiosity, and your questions—we look forward to seeing you there!

For additional information on the Career Fair and Open MDPI positions, please visit the following links:

• Learn more about the U of T Career Fair;
• Explore Careers with MDPI Canada.

Conference: 28th EVER Congress
Date: 9–11 October 2025
Location: Florence, Italy

MDPI will be attending the 28th EVER Congress (EVER 2025) as an exhibitor, welcoming researchers from diverse backgrounds to visit and share their latest ideas.

EVER is the leading ophthalmological research association in Europe, which covers all areas of ophthalmology and the visual sciences. It can be considered as a bridge between basic scientists and clinical eye research of ophthalmology (including retina, glaucoma, cornea and ocular surface, oncology, pediatric ophthalmology, strabismus, neuro-ophthalmology, and lens disorders). It is mostly interested in translational research within all areas of ophthalmology and the visual sciences. This is being introduced during the congress annual meetings, where the best researchers and ophthalmology clinicians are present. It is essential for EVER that these congress meetings are attended by delegates from all over the world.

The following open access journals will be represented at the conference:

• Journal of Clinical Medicine;
• Medicina;
• Reports;
• Medical Sciences;
• Vision;
• Children;
• Diseases;
• Journal of Eye Movement Research.

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://evercongress.org/.

MDPI will be attending the 84th Annual Meeting of the Japanese Cancer Association from 25 to 27 September 2025 in Kanazawa City, Ishikawa Prefecture, Japan. We welcome researchers from diverse backgrounds to visit our booth and share their latest ideas with us.

The Annual Meeting is a major event regularly organized by the Japanese Cancer Association to disseminate the latest achievements in cancer research. The 84th Annual Meeting, held under the theme “Believe in the power of cancer research”, emphasizes innovative basic research to deepen our understanding of cancer biology and drive the development of new therapeutic strategies. A total of 20 symposia will be held, each focusing on a specific, cutting-edge research topic, and special lectures will be presented by world-leading cancer researchers. The conference will provide participants with the opportunity to engage with the forefront of international research.

The following MDPI journals will be represented:

• Cancers;
• Journal of Clinical Medicine;
• Diseases;
• Current Oncology;
• Clinics and Practice;
• Medical Sciences;
• Onco;
• Radiation.

We welcome you to visit the MDPI booth (#J-2) at the Hotel Nikko Kanazawa. Our representatives are excited to meet you in person and address any questions you may have. For further details about the conference, please visit the following website: https://www.c-linkage.co.jp/jca2025/en/.

Conference: 2025 BMES Annual Meeting
Date: 8–12 October 2025
Location: San Diego, USA

MDPI will be attending the 2025 BMES Annual Meeting of the Biomedical Engineering Society as an exhibitor from 8 to 12 October 2025, welcoming researchers from diverse backgrounds to visit and share their latest ideas.

The Annual Meeting is the premier gathering of biomedical engineers and allied fields, and 2025 promises to be another standout year following a record-breaking meeting in 2024. This year’s event will bring together more than 5,500 attendees, focusing on health and wellness through engineering innovation.

Join us in the beautiful coastal city of San Diego, California, for the 2025 Annual Meeting. We look forward to seeing you in San Diego in October 2025!

The following MDPI journals will be represented at the Annual Meeting:

• Biomimetics;
• Bioengineering;
• Diseases;
• Sensors;
• Biomedicines;
• Biomechanics; 
• CIMB; 
• Micromachines; 
• BioChem.

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information, please visit https://www.bmes.org/2025/annualmeeting.